Retour
Fourchette du Jour
0,65 €
0,65 €
Fourchette 52 Semaines
0,65 €
0,65 €
Volume
400
Moyenne 50J / 200J
0,65 €
/
0,65 €
Clôture Précédente
0,65 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 10,6 | 0,4 |
| P/B | 1,0 | 2,9 |
| ROE % | 9,6 | 3,8 |
| Net Margin % | 26,3 | 3,9 |
| Rev Growth 5Y % | -0,7 | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2027 |
0,11 €
0,11 € – 0,11 €
|
270 M | 1 |
| FY2026 |
0,10 €
0,10 € – 0,10 €
|
250 M | 1 |
Points Clés
Revenue declined -0,65% annually over 5 years
Earnings declined -20,74% over the past year
Net margin of 26,25% shows strong profitability
Debt/Equity of 0,03 — conservative balance sheet
Negative free cash flow of -260,42M
P/E of 10,64 — trading at a low valuation
Croissance
Revenue Growth (5Y)
-0,65%
Revenue (1Y)-87,94%
Earnings (1Y)-20,74%
FCF Growth (3Y)N/A
Qualité
Return on Equity
9,61%
ROIC8,23%
Net Margin26,25%
Op. Margin31,29%
Sécurité
Debt / Equity
0,03
Current Ratio19,65
Interest Coverage83,67
Valorisation
P/E Ratio
10,64
P/B Ratio1,01
EV/EBITDA4,48
Dividend Yield0,07%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -87,94% | Revenue Growth (3Y) | -0,23% |
| Earnings Growth (1Y) | -20,74% | Earnings Growth (3Y) | -69,27% |
| Revenue Growth (5Y) | -0,65% | Earnings Growth (5Y) | -10,05% |
| Profitability | |||
| Revenue (TTM) | 194,41M | Net Income (TTM) | 51,03M |
| ROE | 9,61% | ROA | 8,52% |
| Gross Margin | 61,16% | Operating Margin | 31,29% |
| Net Margin | 26,25% | Free Cash Flow (TTM) | -260,42M |
| ROIC | 8,23% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,03 | Current Ratio | 19,65 |
| Interest Coverage | 83,67 | Dividend Yield | 0,07% |
| Valuation | |||
| P/E Ratio | 10,64 | P/B Ratio | 1,01 |
| P/S Ratio | 2,79 | PEG Ratio | -0,12 |
| EV/EBITDA | 4,48 | Dividend Yield | 0,07% |
| Market Cap | 542,78M | Enterprise Value | 272,84M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 194,41M | 1,61B | 195,29M | 221,60M | 199,55M |
| Net Income | 51,03M | 64,38M | 540,39M | 82,68M | 77,94M |
| EPS (Diluted) | 0,06 | 0,60 | 0,08 | 0,10 | 0,09 |
| Gross Profit | 118,90M | 1,07B | 134,12M | 139,02M | 142,53M |
| Operating Income | 60,84M | 576,92M | 79,93M | 103,97M | 98,80M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 598,72M | 586,72M | 567,74M | 543,45M | 494,82M |
| Total Liabilities | 37,49M | 40,29M | 52,97M | 64,85M | 40,95M |
| Shareholders' Equity | 537,98M | 524,42M | 495,03M | 461,41M | 438,31M |
| Total Debt | 16,26M | 15,89M | 16,88M | 13,20M | 16,47M |
| Cash & Equivalents | 286,19M | 228,29M | 128,04M | 254,86M | 212,90M |
| Current Assets | 522,16M | 510,31M | 492,32M | 471,47M | 420,19M |
| Current Liabilities | 26,57M | 235,35M | 42,24M | 53,58M | 27,32M |